Literature DB >> 15125666

Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis.

Didier Boturyn1, Jean-Luc Coll, Elisabeth Garanger, Marie-Christine Favrot, Pascal Dumy.   

Abstract

The alpha(V)beta(3) integrin receptor plays an important role in human metastasis and tumor-induced angiogenesis. c[-RGDfV-] peptide represents a selective alpha(V)beta(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. We report here the modular synthesis and biological characterization of template assembled cyclopeptides as a multimeric system for targeting and endocytosis of cells expressing alpha(V)beta(3) integrin. c[-RGDfK-] was cleanly assembled in a multivalent mode by chemoselective oxime bond formation to a cyclodecapeptides template labeled by different reporter groups. Binding propensity to the alpha(V)beta(3) receptor and the associated good uptake property displayed by the multivalent molecules demonstrated the interest in the RAFT molecule to design new multimeric system with hitherto unreported properties. These compounds offer an interesting perspective for the reevaluation of integrins as angiogenesis regulators (Hynes, R. O. Nature Med. 2003, 9, 918-921) as well as for the design of more sophisticated systems such as molecular conjugate vectors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125666     DOI: 10.1021/ja049926n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  49 in total

1.  Advantages of RGD peptides for directing cell association with biomaterials.

Authors:  Susan L Bellis
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

2.  Application of click-click chemistry to the synthesis of new multivalent RGD conjugates.

Authors:  Mathieu Galibert; Lucie Sancey; Olivier Renaudet; Jean-Luc Coll; Pascal Dumy; Didier Boturyn
Journal:  Org Biomol Chem       Date:  2010-09-09       Impact factor: 3.876

3.  PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.

Authors:  Haokao Gao; Lixin Lang; Ning Guo; Feng Cao; Qimeng Quan; Shuo Hu; Dale O Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-25       Impact factor: 9.236

4.  Targeted delivery of a proapoptotic peptide to tumors in vivo.

Authors:  Sandrine Dufort; Lucie Sancey; Amandine Hurbin; Stéphanie Foillard; Didier Boturyn; Pascal Dumy; Jean-Luc Coll
Journal:  J Drug Target       Date:  2010-12-24       Impact factor: 5.121

5.  In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.

Authors:  Lucie Sancey; Valérie Ardisson; Laurent M Riou; Mitra Ahmadi; Danièle Marti-Batlle; Didier Boturyn; Pascal Dumy; Daniel Fagret; Catherine Ghezzi; Jean-Philippe Vuillez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-04       Impact factor: 9.236

Review 6.  Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Authors:  Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-12-17       Impact factor: 4.200

7.  Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.

Authors:  S-T Chou; Q Leng; P Scaria; M Woodle; A J Mixson
Journal:  Cancer Gene Ther       Date:  2011-08-05       Impact factor: 5.987

8.  Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.

Authors:  Zhaofei Liu; Shuanglong Liu; Fan Wang; Shuang Liu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-19       Impact factor: 9.236

9.  In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD.

Authors:  Julien Dimastromatteo; Laurent M Riou; Mitra Ahmadi; Guillaume Pons; Eric Pellegrini; Alexis Broisat; Lucie Sancey; Tatiana Gavrilina; Didier Boturyn; Pascal Dumy; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2010-01-20       Impact factor: 5.952

10.  Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer.

Authors:  Ryogo Minamimoto; Amer Karam; Mehran Jamali; Amir Barkhodari; Sanjiv Sam Gambhir; Oliver Dorigo; Andrei Iagaru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.